Health Condition 1: K529- Noninfective gastroenteritis and colitis, unspecified
Conditions
Interventions
None listed
Sponsors
Ayurvedic and Unani Tibbia college karol bagh
Eligibility
Inclusion criteria
Inclusion criteria: Patients between the age group of 21-60 years of age irrespective of sex Patints Willing and ready to sign the informed consent Patients suffering from symptoms of irritable bowel syndrome i.e. Muhu baddha drava Durgandhita Pichchhila Mal pravriti Aruchi Udara Shoola Vistambha Praseka Gaurava etc. over the past 3 months with symptom onset at least 6 months prior to diagnosis.
Exclusion criteria
Exclusion criteria: Patients having medical history of Intestinal Obstruction Crohns disease Ulcerative Colitis are excluded. Patients suffering from Acute diarrhoea Intestinal T.B. Gastric and Peptic ulcer uncontrolled D.M. and H.T. Gulma Arsha etc. Patients having any type of surgery or malignancyd Known case of serious hepatic cardiac or kidney diseases. Patients with known hypersensitivity to the trial drug. Patients on prolonged medication with corticosteroids antidepressants anticholinergics immunosuppressant etc. or any other drugs that may have an influence on the outcome of the study. Patients with poorly controlled hypertension systolic 140 and diastolic 90 mm of Hg despite of antihypertensive agents. Patients who have completed participation in any other clinical trial drugs ortheir ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Expected Primary Outcome is improvement in the symptoms of grahani rogaTimepoint: At base line and 13 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The Expected secondary outcome is the safety of the therapy under investigation. At the end of the study Safety of drug can be noted with any side effectTimepoint: 2 weeks & 13 weeks | — |
Countries
India
Contacts
Public ContactDr Monika Tyagi
Ayurveda and Unani Tibbia College New Delhi
Outcome results
None listed